Results 41 to 50 of about 731 (137)

Gamma-Oryzanol Attenuates Aortic Valve Interstitial Cell Calcification via Suppression of BMP2-SMAD and MAPK Signaling Pathways. [PDF]

Biomolecules
Thapa M, Shiwakoti S, Gong D, Ko JY, Gwak YH, Oak MH.   +5 more
europepmc   +1 more source

Origins of Noncovalent Interactions in Lignocellulosic Biomass and Potential Implications on Recalcitrance. [PDF]

Chemphyschem
Romero-Montalvo E, Mushrif SH.
europepmc   +1 more source

Ivacaftor-tezacaftor-elexacaftor, tezacaftor-ivacaftor and lumacaftor-ivacaftor for treating cystic fibrosis: a systematic review and economic evaluation.

Health Technol Assess
Edwards SJ, Farrar BG, Ennis K, Downes N, Wakefield V, Mackenzie I, Walters A, Jhita T.   +7 more
europepmc   +1 more source

Anterior ischemic optic neuropathy in patients treated with semaglutide: report of four cases with a possible association. [PDF]

BMC Ophthalmol
Ahmadi H, Hamann S.
europepmc   +1 more source

Integrated Transcriptomic and Metabolomic Analyses Reveal Key Genes Involved in Phenylpropanoid Metabolism in <i>Lonicera macranthoides</i> Flowers. [PDF]

Genes (Basel)
Li Z, Zhou Z, Feng H, Wang Y, Zeng Z, Hou Q, Shen L.   +6 more
europepmc   +1 more source

Syringin and Phillygenin-Natural Compounds with a Potential Role in Preventing Lipid Deposition in Macrophages in the Context of Human Atherosclerotic Plaque. [PDF]

Int J Mol Sci
Filipek A, Sadowska A, Skłodowska M, Muskała M, Czepielewska E.   +4 more
europepmc   +1 more source

PPAR-mediated reduction of lipid accumulation in hepatocytes involves the autophagy-lysosome-mitochondrion axis. [PDF]

Ann Med
Cetti F, Ossoli A, Garavaglia C, Da Dalt L, Norata GD, Gomaraschi M.   +5 more
europepmc   +1 more source

Therapy in diabetic dyslipidemia.

Indian J Pharmacol
Maheswari U.
europepmc   +1 more source

Metabolic signatures and a diagnostic model for citrin deficiency based on urinary organic acids. [PDF]

Clin Transl Med
Wang P, Chen P, Yang X, Cen Z, Zhang Y, He Q, Wu B, Huang X.   +7 more
europepmc   +1 more source

Saroglitazar Ameliorates Pulmonary Fibrosis Progression in Mice by Suppressing NF-κB Activation and Attenuating Macrophage M1 Polarization. [PDF]

Medicina (Kaunas)
Zhang Y, Lin J, Han X, Chen X.
europepmc   +1 more source